In obese individuals, atherogenic dyslipidemia is a very common and important factor in the
increased risk of cardiovascular disease. Adiposity-associated dyslipidemia is characterized …

Adiponectin is an insulin-sensitizing adipokine with anti-diabetic, anti-atherogenic, anti-
inflammatory and cardioprotective properties. This adipokine is secreted from adipocytes …

Recent studies emphasize the role played by adiponectin in the homeostasis of adipose
tissue and in the pathogenesis of the metabolic syndrome, type 2 diabetes, and …

Context: Mouse studies suggest that adropin, a peptide hormone, is required for metabolic
homeostasis and prevention of obesity-associated insulin resistance. Whether obesity and …

Roux-en-Y gastric bypass (RYGB) greatly improves glycaemic control in morbidly obese
patients with type 2 diabetes, in many even before significant weight loss. Understanding the …

Adipose tissue inflammation mediates the association between excessive body fat
accumulation and several chronic inflammatory diseases. A high prevalence of obesity …

Adiponectin is an adipocyte hormone that links visceral adiposity with insulin resistance and
atherosclerosis. It is unique among adipocyte-derived hormones in that its circulating …

Adiponectin is an insulin sensitizing fat cell (FC) hormone whose levels are related to
adipose tissue (AT) mass and depot distribution. We hypothesized that the nature of AT …

Bariatric surgery has been shown to improve glucose tolerance, although the mechanism
has not been fully elucidated. Animal studies have suggested important roles of bile acid …

Background: Rates of distal and junctional adenocarcinomas are increasing in Western
countries. Methods: Systematic review of epidemiological evidence linking obesity to …